STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 52 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,798,000 | -34.0% | 1,371,400 | -4.0% | 0.00% | -20.0% |
| Q2 2021 | $4,241,000 | -0.6% | 1,427,900 | -7.7% | 0.01% | 0.0% |
| Q1 2021 | $4,268,000 | -19.8% | 1,546,290 | -29.4% | 0.01% | -16.7% |
| Q4 2020 | $5,320,000 | +61.5% | 2,189,200 | +39.5% | 0.01% | +100.0% |
| Q3 2020 | $3,295,000 | -30.5% | 1,569,189 | +25.1% | 0.00% | -25.0% |
| Q2 2020 | $4,742,000 | +160.1% | 1,254,600 | +30.1% | 0.00% | +100.0% |
| Q1 2020 | $1,823,000 | +35.9% | 964,328 | +50.3% | 0.00% | +100.0% |
| Q4 2019 | $1,341,000 | +171.5% | 641,600 | +210.3% | 0.00% | – |
| Q3 2019 | $494,000 | -5.2% | 206,800 | +24.4% | 0.00% | – |
| Q2 2019 | $521,000 | +93.7% | 166,300 | +208.0% | 0.00% | – |
| Q1 2019 | $269,000 | -33.1% | 54,000 | -34.8% | 0.00% | – |
| Q3 2018 | $402,000 | -80.8% | 82,800 | -71.6% | 0.00% | -100.0% |
| Q2 2018 | $2,092,000 | +97.7% | 292,000 | +144.1% | 0.00% | 0.0% |
| Q1 2018 | $1,058,000 | – | 119,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
| Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
| Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
| Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
| Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
| ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
| PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
| NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
| Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
| Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |